Efficacy and Safety Rifapentine-Containing Regimen for Drug Sensitive Tuberculosis: Systematic Review and Meta-Analysis
Open Access
- 26 April 2024
- journal article
- review article
- Published by European Publishing in Pneumon
- Vol. 37 (2) , 1-8
Abstract
Introduction: Newer regimens are needed and expected to have a shorter therapeutic time to increase drug adherence to completion in drug sensitive tuberculosis (DS-TB) patients. Methods: We conducted first a systematic review and meta-analysis of prior studies to evaluate the effectiveness...Keywords
This publication has 25 references indexed in Scilit:
- Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugeesJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2021
- Four-Month Rifapentine Regimens with or without Moxifloxacin for TuberculosisNew England Journal of Medicine, 2021
- Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosisCochrane Database of Systematic Reviews, 2019
- A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisNature Medicine, 2018
- Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysisAmerican Journal of Preventive Medicine, 2018
- A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infectionPharmacoepidemiology and Drug Safety, 2018
- Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?Expert Review of Clinical Pharmacology, 2017
- Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure–response relations from two phase II clinical trialsClinical Pharmacology & Therapeutics, 2017
- High-Dose Rifapentine with Moxifloxacin for Pulmonary TuberculosisNew England Journal of Medicine, 2014
- Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials ConsortiumThe Journal of Infectious Diseases, 2012